Annual Working Capital
$86.98 M
-$25.65 M-22.77%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual working capital is $86.98 million, with the most recent change of -$25.65 million (-22.77%) on December 31, 2023.
- During the last 3 years, ATOS annual working capital has risen by +$59.88 million (+220.98%).
- ATOS annual working capital is now -37.02% below its all-time high of $138.11 million, reached on December 31, 2021.
Performance
ATOS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$71.31 M
-$4.71 M-6.19%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly working capital is $71.31 million, with the most recent change of -$4.71 million (-6.19%) on September 30, 2024.
- Over the past year, ATOS quarterly working capital has dropped by -$22.89 million (-24.30%).
- ATOS quarterly working capital is now -50.49% below its all-time high of $144.03 million, reached on June 30, 2021.
Performance
ATOS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ATOS Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.8% | -24.3% |
3 y3 years | +221.0% | -49.5% |
5 y5 years | +907.5% | -49.5% |
ATOS Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -37.0% | at low | -48.4% | at low |
5 y | 5-year | -37.0% | +569.3% | -50.5% | +766.0% |
alltime | all time | -37.0% | >+9999.0% | -50.5% | +5174.4% |
Atossa Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $71.31 M(-6.2%) |
Jun 2024 | - | $76.02 M(-7.0%) |
Mar 2024 | - | $81.73 M(-6.0%) |
Dec 2023 | $86.98 M(-22.8%) | $86.98 M(-7.7%) |
Sep 2023 | - | $94.20 M(-8.1%) |
Jun 2023 | - | $102.53 M(-5.0%) |
Mar 2023 | - | $107.92 M(-4.2%) |
Dec 2022 | $112.63 M(-18.5%) | $112.63 M(-6.6%) |
Sep 2022 | - | $120.53 M(-7.0%) |
Jun 2022 | - | $129.63 M(-3.6%) |
Mar 2022 | - | $134.53 M(-2.6%) |
Dec 2021 | $138.11 M(+409.7%) | $138.11 M(-2.3%) |
Sep 2021 | - | $141.31 M(-1.9%) |
Jun 2021 | - | $144.03 M(+3.1%) |
Mar 2021 | - | $139.65 M(+415.3%) |
Dec 2020 | $27.10 M(+108.5%) | $27.10 M(+177.9%) |
Sep 2020 | - | $9.75 M(+18.4%) |
Jun 2020 | - | $8.23 M(-23.5%) |
Mar 2020 | - | $10.76 M(-17.2%) |
Dec 2019 | $13.00 M(+50.5%) | $13.00 M(-12.4%) |
Sep 2019 | - | $14.84 M(-14.5%) |
Jun 2019 | - | $17.36 M(-10.0%) |
Mar 2019 | - | $19.29 M(+123.4%) |
Dec 2018 | $8.63 M(+29.4%) | $8.63 M(-16.7%) |
Sep 2018 | - | $10.37 M(-22.6%) |
Jun 2018 | - | $13.40 M(+167.2%) |
Mar 2018 | - | $5.01 M(-24.8%) |
Dec 2017 | $6.67 M | $6.67 M(+255.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2017 | - | $1.88 M(-9.3%) |
Jun 2017 | - | $2.07 M(+179.0%) |
Mar 2017 | - | $742.00 K(-66.4%) |
Dec 2016 | $2.21 M(+23.1%) | $2.21 M(-40.3%) |
Sep 2016 | - | $3.70 M(+537.2%) |
Jun 2016 | - | $580.70 K(-71.8%) |
Mar 2016 | - | $2.06 M(+14.8%) |
Dec 2015 | $1.79 M(-74.7%) | $1.79 M(-71.3%) |
Sep 2015 | - | $6.25 M(-39.6%) |
Jun 2015 | - | $10.34 M(+31.2%) |
Mar 2015 | - | $7.88 M(+11.4%) |
Dec 2014 | $7.08 M(+32.0%) | $7.08 M(-30.5%) |
Sep 2014 | - | $10.18 M(-22.4%) |
Jun 2014 | - | $13.11 M(-21.1%) |
Mar 2014 | - | $16.62 M(+210.0%) |
Dec 2013 | $5.36 M(+1481.7%) | $5.36 M(-19.4%) |
Sep 2013 | - | $6.65 M(+85.8%) |
Jun 2013 | - | $3.58 M(+60.6%) |
Mar 2013 | - | $2.23 M(+557.8%) |
Dec 2012 | $338.90 K(-76.4%) | $338.90 K(-124.1%) |
Sep 2012 | - | -$1.41 M(+101.4%) |
Jun 2012 | - | -$697.70 K(-260.0%) |
Mar 2012 | - | $436.00 K(-69.6%) |
Dec 2011 | $1.43 M(-267.3%) | $1.43 M(-45.9%) |
Sep 2011 | - | $2.65 M(-409.5%) |
Dec 2010 | -$856.60 K | -$856.60 K(+62.3%) |
Sep 2010 | - | -$527.70 K(+805.1%) |
Jun 2010 | - | -$58.30 K |
FAQ
- What is Atossa Therapeutics annual working capital?
- What is the all time high annual working capital for Atossa Therapeutics?
- What is Atossa Therapeutics annual working capital year-on-year change?
- What is Atossa Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly working capital year-on-year change?
What is Atossa Therapeutics annual working capital?
The current annual working capital of ATOS is $86.98 M
What is the all time high annual working capital for Atossa Therapeutics?
Atossa Therapeutics all-time high annual working capital is $138.11 M
What is Atossa Therapeutics annual working capital year-on-year change?
Over the past year, ATOS annual working capital has changed by -$25.65 M (-22.77%)
What is Atossa Therapeutics quarterly working capital?
The current quarterly working capital of ATOS is $71.31 M
What is the all time high quarterly working capital for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly working capital is $144.03 M
What is Atossa Therapeutics quarterly working capital year-on-year change?
Over the past year, ATOS quarterly working capital has changed by -$22.89 M (-24.30%)